Earnings Call · Q1 FY2023·2023-05-03

Q1 23EPS -100.00%*·Rev n/aQ4 22EPS -13.89%·Rev n/aQ3 22EPS -3.57%·Rev n/aQ2 22EPS -5.62%·Rev n/a⚠ consensus missing

NEUROCRINE BIOSCIENCES INC NBIX

Todd Tushla — Head of Investor Relations

Kevin Gorman — Chief Executive Officer

Matt Abernethy — Chief Financial Officer

Eric Benevich — Chief Commercial Officer

Eiry Roberts — Chief Medical Officer

−4.7%1d on move date−4.0% vs SPY3d−5.8%5d−6.0%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NBIX calls or request research access.

More NBIX calls Browse calls Request research access